Lantheus Holdings (LNTH) Free Cash Flow (2014 - 2026)
Lantheus Holdings (LNTH) posted quarterly Free Cash Flow of $121.9 million for Q1 2026, up 19.85% year-over-year from $101.7 million in Q1 2025, and up 105.2% quarter-over-quarter from $59.4 million in Q4 2025.
Lantheus Holdings (LNTH) Free Cash Flow (2014 - 2026) Analysis & Trends
Lantheus Holdings (LNTH) has reported Free Cash Flow for 13 consecutive years, with $121.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Free Cash Flow rose 19.85% year-over-year to $121.9 million; the TTM figure through Mar 2026 stood at $374.2 million (down 28.17% YoY), while the FY2025 annual figure was $354.1 million, down 34.4% from the prior year.
- Free Cash Flow rose to $121.9 million in Q1 2026 per LNTH's latest filing, from $59.4 million in the prior quarter.
- Across five years, Free Cash Flow topped out at $233.6 million in Q4 2024 and bottomed at -$43.7 million in Q2 2023.
- Historically, Free Cash Flow has averaged $92.8 million across 5 years, with a median of $100.0 million in 2025.
- Annual changes were most pronounced in 2022 — Free Cash Flow jumped 4874.56% — and 2023, when it slumped 164.01%.
- Lantheus Holdings' Free Cash Flow stood at $87.0 million in 2022, then soared by 73.16% to $150.7 million in 2023, then soared by 55.05% to $233.6 million in 2024, then tumbled by 74.57% to $59.4 million in 2025, then surged by 105.2% to $121.9 million in 2026.
- Business Quant data shows LNTH's Free Cash Flow at $121.9 million in Q1 2026, $59.4 million in Q4 2025, and $100.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 307.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 538.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 1.14 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 205.60 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 329.00 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 128.60 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 244.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Lantheus Holdings | 6.52 Bn | 5.93 Bn | 241.86 Mn | 89.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 89.87 Mn |
| Jun 30, 2026 | 89.87 Mn |
| Mar 31, 2026 | 121.90 Mn |
| Mar 31, 2026 | 121.90 Mn |
| Dec 31, 2025 | 59.41 Mn |
| Dec 31, 2025 | 59.41 Mn |
| Sep 30, 2025 | 99.98 Mn |
| Sep 30, 2025 | 99.98 Mn |
| Jun 30, 2025 | 92.96 Mn |
| Jun 30, 2025 | 92.96 Mn |
| Mar 31, 2025 | 101.71 Mn |
| Mar 31, 2025 | 101.71 Mn |
| Dec 31, 2024 | 233.58 Mn |
| Dec 31, 2024 | 233.58 Mn |
| Sep 30, 2024 | 128.06 Mn |
| Sep 30, 2024 | 128.06 Mn |
| Jun 30, 2024 | 57.66 Mn |
| Jun 30, 2024 | 57.66 Mn |
| Mar 31, 2024 | 120.39 Mn |
| Mar 31, 2024 | 120.39 Mn |